Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced and Selected Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02922764
What this trial is testing

RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more
Inspirna, Inc. 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822
What this trial is testing

Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Who this might be right for
Advanced Solid Tumor
Incyte Corporation 73
Early research (Phase 1)UnknownNCT03710265
What this trial is testing

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 206
Testing effectiveness (Phase 2)Looking for participantsNCT06819735
What this trial is testing

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Domain Therapeutics Australia Pty Ltd 125
Early research (Phase 1)Study completedNCT03156114
What this trial is testing

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 172
Testing effectiveness (Phase 2)UnknownNCT04699643
What this trial is testing

FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EverNov Medicines (Zhuhai Hengqin) Co., Ltd 80
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Early research (Phase 1)Study completedNCT02516527
What this trial is testing

Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors

Who this might be right for
Melanoma
Bristol-Myers Squibb 25
Testing effectiveness (Phase 2)Ended earlyNCT01708161
What this trial is testing

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Who this might be right for
PIK3CA Mutated Advanced Solid TumorsPIK3CA Amplified Advanced Solid Tumors
Novartis Pharmaceuticals 47
Early research (Phase 1)Looking for participantsNCT06596473
What this trial is testing

BG-C477 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeOne Medicines 310
Early research (Phase 1)Study completedNCT02533674
What this trial is testing

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
PharmaMar 57
Very early researchLooking for participantsNCT05141474
What this trial is testing

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

Who this might be right for
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology 10
Testing effectiveness (Phase 2)WithdrawnNCT04976660
What this trial is testing

TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors

Who this might be right for
Colorectal CancerGastric CancerHepatocellular Carcinoma+1 more
Tarus Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Not applicableEnded earlyNCT01904916
What this trial is testing

CPCT-05 Biopsy Protocol Patient Selection

Who this might be right for
Solid TumorsMetastatic Disease
P.O. Witteveen 195
Early research (Phase 1)Looking for participantsNCT05841563
What this trial is testing

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

Who this might be right for
Advanced Solid Tumor
PharmaMar 125
Early research (Phase 1)Looking for participantsNCT04969835
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Who this might be right for
Salivary Gland TumorUrothelial CarcinomaOvarian Carcinoma+2 more
Avacta Life Sciences Ltd 158
Early research (Phase 1)Study completedNCT01363232
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid TumorsSelected Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 89
Testing effectiveness (Phase 2)Looking for participantsNCT05473156
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)+1 more
AP Biosciences Inc. 168
Early research (Phase 1)Study completedNCT03523390
What this trial is testing

Phase I/Ib Multiple Ascending Dose Study in China

Who this might be right for
Metastatic Solid Tumors
Merck KGaA, Darmstadt, Germany 24
Next Page